Brainstorm Cell Therapeutics Inc. (BCLI)
OTCMKTS
· Delayed Price · Currency is USD
0.6000
-0.0090 (-1.48%)
At close: Dec 5, 2025
Brainstorm Cell Therapeutics Employees
Brainstorm Cell Therapeutics had 27 employees as of December 31, 2024. The number of employees decreased by 2 or -6.90% compared to the previous year.
Employees
27
Change (1Y)
-2
Growth (1Y)
-6.90%
Revenue / Employee
n/a
Profits / Employee
-$471,565
Market Cap
6.62M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 116 |
| Zomedica | 152 |
Brainstorm Cell Therapeutics News
- 21 days ago - BrainStorm Cell Therapeutics GAAP EPS of -$0.91, revenue of $7M - Seeking Alpha
- 21 days ago - BrainStorm Cell Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 5 weeks ago - Halper Sadeh LLC Encourages Brainstorm Cell Therapeutics Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 4 months ago - Brainstorm Cell Therapeutics outlines readiness for Phase IIIb ALS trial as funding and regulatory developments shape next steps - Seeking Alpha
- 4 months ago - Brainstorm Cell Therapeutics Inc. (BCLI) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - BrainStorm Cell Therapeutics GAAP EPS of -$0.77 - Seeking Alpha
- 4 months ago - BrainStorm Cell Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 4 months ago - BrainStorm Cell Therapeutics Q2 2025 Earnings Preview - Seeking Alpha